Lauria PB, Del Puerto HL, Reis AM, Candido AL, Reis FM. Low plasma atrial natriuretic peptide: a new piece in the puzzle of polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2013;98(12):4882–9.
Wiencek JR, McCartney CR, Chang AY, Straseski JA, Auchus RJ, Woodworth A. Challenges in the assessment and diagnosis of polycystic ovary syndrome. Clin Chem. 2019;65(3):370–7.
Article CAS PubMed Google Scholar
Yang Y, Ding M, Di N, Azziz R, Yang D, Zhao X. Close correlation between hyperandrogenism and insulin resistance in women with polycystic ovary syndrome—based on liquid chromatography with tandem mass spectrometry measurements. J Clin Lab Anal. 2019;33(3):e22699.
Balen A, Michelmore K. What is polycystic ovary syndrome? Are national views important? Hum Reprod. 2002;17(9):2219–27.
Goldrat O, Delbaere A. PCOS: update and diagnostic approach. Clin Biochem. 2018;62:24–31.
Chazenbalk G, Trivax BS, Yildiz BO, Bertolotto C, Mathur R, Heneidi S, Azziz R. Regulation of adiponectin secretion by adipocytes in the polycystic ovary syndrome: role of tumor necrosis factor-α. J Clin Endocrinol Metabolism. 2010;95(2):935–42.
Agacayak E, Tunc SY, Sak S, Basaranoglu S, Yüksel H, Turgut A, Gul T. Levels of neopterin and other inflammatory markers in obese and non-obese patients with polycystic ovary syndrome. Med Sci Monitor: Int Med J Experimental Clin Res. 2015;21:2446.
Semenov AG, Tamm NN, Seferian NN, Postnikov KR, Karpova AB, Serebryanaya NS, Koshkina DV, Krasnoselsky EV, Katrukha MI. Processing of pro-B-type natriuretic peptide: furin and Corin as candidate convertases. Clin Chem. 2010;56(7):1166–76. https://doi.org/10.1373/clinchem.2010.143883
Zhang X, Gu X, Zhang Y, Dong N, Wu Q. Corin: a key mediator in sodium homeostasis, vascular remodeling, and heart failure. Biology. 2022;11(5):717.
Article CAS PubMed PubMed Central Google Scholar
Dong N, Chen S, Wang W, Zhou Y, Wu Q. Corin in clinical laboratory diagnostics. Clin Chim Acta. 2012;413(3–4):378–83.
Article CAS PubMed Google Scholar
Yu R, Han X, Zhang X, Wang Y, Wang T. Circulating soluble corin as a potential biomarker for cardiovascular diseases: a translational review. Clin Chim Acta. 2018;485:106–12.
Article CAS PubMed Google Scholar
Boshku AA, Panova DI. Correlation of adiponectin and resistin with atherogenic markers in insulin resistant and non-insulin resistant adolescent women with polycystic ovary syndrome. Endocrine Abstracts. 2022; 81.
Peng H, Zhang Q, Shen H, Liu Y, Chao X, Tian H, Cai X, Jin J. Association between serum soluble Corin and obesity in Chinese adults: a cross-sectional study. Obesity. 2015;23(4):856–61.
Article CAS PubMed Google Scholar
Moro C, Pasarica M, Elkind-Hirsch K, Redman LM. Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome. J Clin Endocrinol Metabolism. 2009;94(7):2579–86.
Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.
von Eckardstein A, Roth HJ, Jones G, Preston S, Szekeres T, Imdahl R, Conti M, Blanckaert N, Jose D, Thiery J, Feldmann L. Cobas 8000 modular analyzer series evaluated under routine-like conditions at 14 sites in Australia, Europe, and the United States. J Lab Autom. 2013;18(4):306–27.
Paredes S, Fonseca L, Ribeiro L, Ramos H, Oliveira JC, Palma I. Novel and traditional lipid profiles in metabolic syndrome reveal a high atherogenicity. Sci Rep. 2019;9(1):11792.
Article PubMed PubMed Central Google Scholar
Nauck M, Marz W, Jarausch J, Cobbaert C, Sagers A, Bernard D, Delanghe J, Honauer G, Lehmann P, Oestrich E, von Eckardstein A. Multicenter evaluation of a homogeneous assay for HDL-cholesterol without sample pretreatment. Clin Chem. 1997;43(9):1622–9.
Article CAS PubMed Google Scholar
Nauck M, Graziani MS, Bruton D, Cobbaert C, Cole TG, Lefevre F, Riesen W, Bachorik PS, Rifai N. Analytical and clinical performance of a detergent-based homogeneous LDL-cholesterol assay: a multicenter evaluation. Clin Chem. 2000;46(4):506–14.
Article CAS PubMed Google Scholar
Ribeiro FA, Resende EA, Silva AP, Tomé JM, Palhares HM, Borges MD. Metabolic and hormonal assessment of adolescent and young adult women with prior premature adrenarche. Clinics. 2019;74.
Liu Y, Hu J, Yu Q, Zhang P, Han X, Peng H. Increased serum soluble corin in mid-pregnancy is associated with hypertensive disorders of pregnancy. J Women’s Health. 2015;24(7):572–7.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
Article CAS PubMed Google Scholar
Bakeer E, Radwan R, El Mandoury A, Abd El Rahman A, Gad M, Abd El Maksoud S. Anti-müllerian hormone as a diagnostic marker in Egyptian infertile polycystic ovary syndrome females: correlations with vitamin D, total testosterone, dyslipidemia, and anthropometric parameters. J Med Biochem. 2018;37(4):448.
Article CAS PubMed PubMed Central Google Scholar
Wageh A, Houssen M, Gibreel A, Abdelhafez MS, El-Hussiny MA, Elemam OA, El-Adawi N. Serum atrial natriuretic peptide levels among clomiphene citrate resistant polycystic ovarian syndrome patients. Middle East Fertility Soc J. 2018;23(4):370–2.
Ichiki T, Huntley BK, Heublein DM, Sandberg SM, McKie PM, Martin FL, Jougasaki M, Burnett JC Jr. Corin is present in the normal human heart, kidney, and blood, with pro–B-type natriuretic peptide processing in the circulation—clinical chemistry. 2011;57(1):40–7.
Brower M, Brennan K, Pall M, Azziz R. The severity of menstrual dysfunction as a predictor of insulin resistance in PCOS. J Clin Endocrinol Metabolism. 2013;98(12):E1967–71.
Melo AS, Ferriani RA, Navarro PA. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice. Clinics. 2015;70:765–9.
Article PubMed PubMed Central Google Scholar
Tüfekçioğlu G, Keşkek ŞÖ, Dilek O, Yilmaz C. Renal resistive index in patients with polycystic ovary syndrome. Archives Endocrinol Metabolism. 2019;63:288–92.
Blagojević IP, Ignjatović S, Macut D, Kotur-Stevuljević J, Božić-Antić I, Vekić J, Bjekić-Macut J, Kastratović-Kotlica B, Andrić Z, Ilić D. Evaluation of a summary score for dyslipidemia, oxidative stress and inflammation (the DOI score) in women with polycystic ovary syndrome and its relationship with obesity. J Med Biochem. 2018;37(4):476.
Article PubMed PubMed Central Google Scholar
Liu Q, Xie YJ, Qu LH, Zhang MX, Mo ZC. Dyslipidemia involvement in the development of polycystic ovary syndrome. Taiwan J Obstet Gynecol. 2019;58(4):447–53.
Arpaci H. Major determinants of circulating myostatin in polycystic ovary syndrome. Experimental Therapeutic Med. 2019;17(2):1383–9.
Peleg A, Jaffe AS, Hasin Y. Enzyme-linked immunoabsorbent assay for detection of human serine protease corin in blood. Clin Chim Acta. 2009;409(1–2):85–9.
Article CAS PubMed Google Scholar
Dong N, Dong J, Liu P, Xu L, Shi S, Wu Q. Effects of anticoagulants on human plasma soluble corin levels measured by ELISA. Clin Chim Acta. 2010;411(23–24):1998–2003.
Article CAS PubMed PubMed Central Google Scholar
Fathy SA, Abdel Hamid FF, Zabut BM, Jamee AF, Ali MA, Abu Mustafa AM. Diagnostic utility of BNP, corin, and furin as biomarkers for cardiovascular complications in type 2 diabetes mellitus patients. Biomarkers. 2015;20(6–7):460–9.
Article CAS PubMed Google Scholar
Le MT, Le VN, Le DD, Nguyen VQ, Chen C, Cao NT. Exploration of the role of anti-mullerian hormone and LH/FSH ratio in the diagnosis of polycystic ovary syndrome. Clin Endocrinol. 2019;90(4):579–85.
Chen S, Jiang M, Ding T, Wang J, Long P. Calprotectin is a potential prognostic marker for polycystic ovary syndrome. Ann Clin Biochem. 2017;54(2):253–7.
Article CAS PubMed Google Scholar
Vatier C, Christin-Maitre S, Vigouroux C. Role of insulin resistance on fertility–Focus on polycystic ovary syndrome. Ann Endocrinol (Paris). 2022;83(3):199-202.
Zhou H, Liu W, Zhu J, Liu M, Fang C, Wu Q, Dong N. Reduced serum corin levels in patients with osteoporosis. Clin Chim Acta. 2013;426:152–6.
Article CAS PubMed Google Scholar
Miyazaki J, Nishizawa H, Kambayashi A, Ito M, Noda Y, Terasawa S, Kato T, Miyamura H, Shiogama K, Sekiya T, Kurahashi H. Increased levels of soluble corin in pre-eclampsia and fetal growth restriction. Placenta. 2016;48:20–5.
Article CAS PubMed Google Scholar
Peng H, Zhang Q, Cai X, Liu Y, Ding J, Tian H, Chao X, Shen H, Jiang L, Jin J, Zhang Y. Association between high serum soluble Corin and hypertension: a cross-sectional study in a general population of China. Am J Hypertens. 2015;28(9):1141–9.
留言 (0)